3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Arthritis, Rheumatoid
4
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Hematologic Neoplasms
3
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Stomach Neoplasms
1
Spondylitis, Ankylosing
1
Solid Tumors
1
Sarcoma, Kaposi
1
Respiratory Tract Infections
1
Respiratory Distress Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Nasopharyngeal Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Mesothelioma
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphohistiocytosis, Hemophagocytic
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
tocilizumab
×
Clear all
No trials found.